Peter Bencsik
My core mission is to bridge the critical gap between clinical needs and digital solutions. I thrive on translating complex healthcare challenges into actionable, technology-enabled strategies. How can I help you today?
Tailored solutions
Tailored strategies that fit your unique needs.
Cross-domain expertise
Collaborate across domains with experts in the industry.
Agile approach
Break projects down into concrete phases.
Progress insights
Track scope, velocity, and progress over time.
Latest from the Blog

Hosting or driving? What 12,402 EU clinical trials say about Central Europe's place in global pharma
What 12,402 EU clinical trials across all 28 member states actually say about Hungary, Poland, and Central Europe's place in global pharma.

The real problem with clinical trial site selection isn't finding rising stars
Clinical trial sites cluster around the same names EU-wide, not just in Hungary or Poland. What that means for how sponsors choose where to run a trial.

What building a real data pipeline with an AI coding agent actually looks like
What happened when an AI coding agent built a real data pipeline, then was asked to audit its own work and found the bugs the first pass missed.

Navigating the AI Agent Hype: A Practical Look at Hermes, n8n, and OpenCode
After days of troubleshooting, I evaluate the practical utility of Hermes Agent, comparing its autonomous capabilities against purpose-built orchestration and coding tools.

The Mirror at Table Four
A philosophical dialogue between a human and an anthropomorphized AI regarding existence, truth, and the nature of control.

LinkedIn 'Broetry': Why I Hate the Algorithm-Baiting Era
An analysis of the one-sentence-per-line posting style taking over LinkedIn, and why it represents the worst of performative engagement.

AI in the Wet Lab: Optimization, Automation, and the Changing Role of the Scientist
OpenAI's recent wet lab experiment demonstrates significant efficiency gains but raises questions about the future role of human researchers.

Japan's Tech-Driven Response to the Dementia Crisis: Innovation vs. Intimacy
As Japan faces a severe dementia crisis with a shrinking workforce, it turns to AI and robotics like Sharp's Poketomo. We analyze the balance between technological aid, privacy risks, and the irreplaceable human touch.

The CDC’s Primate Research Ban: Balancing Ethics, Innovation, and Readiness
The CDC's sudden directive to end monkey research accelerates the debate on New Approach Methodologies versus established scientific necessity and the hidden costs of transition.